ER, PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer-Reduced CK5 Expression in Metastases.

ER, PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer-Reduced CK5 Expression in Metastases.

Item
http://www.wikidata.org/entity/Q36629859
Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cellsLoss of LKB1 disrupts breast epithelial cell polarity and promotes breast cancer metastasis and invasion.Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory CoastSteroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism.Pan-cancer subtyping in a 2D-map shows substructures that are driven by specific combinations of molecular characteristics.SIAH and EGFR, Two RAS Pathway Biomarkers, are Highly Prognostic in Locally Advanced and Metastatic Breast CancerDynamic contrast-enhanced breast magnetic resonance imaging for the prediction of early and late recurrences in breast cancer.Prognostic value of Ki-67 in breast cancer patients with positive axillary lymph nodes: a retrospective cohort studyA Comprehensive Model for Predicting Recurrence and Survival in Cases of Chinese Postoperative Invasive Breast CancerThe use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer.Canine mammary tumors as a model for human disease.
P2860

ER, PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer-Reduced CK5 Expression in Metastases.

Item
http://www.wikidata.org/entity/Q36629859
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
ER, PR, HER2, Ki-67 and CK5 in ...... CK5 Expression in Metastases.
@ast
ER, PR, HER2, Ki-67 and CK5 in ...... CK5 Expression in Metastases.
@en
type
label
ER, PR, HER2, Ki-67 and CK5 in ...... CK5 Expression in Metastases.
@ast
ER, PR, HER2, Ki-67 and CK5 in ...... CK5 Expression in Metastases.
@en
prefLabel
ER, PR, HER2, Ki-67 and CK5 in ...... CK5 Expression in Metastases.
@ast
ER, PR, HER2, Ki-67 and CK5 in ...... CK5 Expression in Metastases.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P932
P356
P1433
P1476
ER, PR, HER2, Ki-67 and CK5 in ...... CK5 Expression in Metastases.
@en
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P932